NIH Reporter #5U01HL159880-05

Research Trial to Reduce Pulse Oximetry Overuse in Pediatric Bronchiolitis

This opportunity is a research-focused solicitation from the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health, seeking to reduce pulse oximetry overuse in pediatric bronchiolitis through a hybrid effectiveness-deimplementation trial. - Government Buyer: - National Heart Lung and Blood Institute (NHLBI), National Institutes of Health - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Products/Services Requested: - Hybrid effectiveness-deimplementation trial services - Conduct a research trial to reduce overuse of pulse oximetry in pediatric bronchiolitis - Focus on sustainability and clinical outcomes - No specific products, part numbers, or quantities are listed - Unique or Notable Requirements: - Expertise in clinical research, pediatric care, and implementation science - Ability to conduct hybrid effectiveness-deimplementation trials - Emphasis on sustainable reduction of unnecessary monitoring in clinical settings - Estimated contract value: $1,127,203 - This is a multi-year research project funded by NHLBI

Description

This project aims to conduct a hybrid effectiveness-deimplementation trial to reduce overuse of pulse oximetry in pediatric bronchiolitis, focusing on sustainability and clinical outcomes. The award is funded by the National Heart Lung and Blood Institute (NHLBI) and is part of a multi-year research effort. The solicitation is active and open for bids. No specific response format, liquidated damages, or pre-bid meeting details are provided.

View original listing